Autopsy report · NCT04216693

Digoxin for Patients With Non-alcoholic Steatohepatitis (NASH)

“Administrative decision to terminate.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 2

Sponsor

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Sponsor type

University, hospital or other

Conditions

Nonalcoholic Steatohepatitis

Interventions

Digoxin tablet; Placebo

Participants

0

Sites

1

Countries

China

Trials that died the same way

• Efficacy and Safety of Salkera Emollient Foam in the Treatment of Moderate to Severe Keratosis Pilaris, a Prospective Study
  “terminated due to administrative reasons.” (73% match in meaning)
• Lafiya HIV-status Neutral Study - Protocol
  “terminated by the new administration” (70% match in meaning)
• Modulating Repetitive Negative Thinking Related Brain Networks in Young Adults With Depression
  “Terminated due to PI resignation. Not related to safety, efficacy, or administrative mandate.” (67% match in meaning)
• Evaluating the Effects of an Exercise Intervention on the Gut Microbiota in Stage II-III Colorectal Cancer Survivors
  “Terminated due to low accrual.” (66% match in meaning)
• Real World, Pharmacy-assessed Adherence to New Onset Entresto® (Sacubitril/Valsartan) in Patients With Chronic Heart Failure
  “Terminated due to business decision” (65% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.